Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Bortezomib × Clear all

NCT00052507 2015-07-23

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00051987 2008-02-11

Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms